Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 24, 2018
Bazelet signed a manufacturing and licensing agreement with Israeli medical cannabis pharmaceutical product developer Alvit LCS Pharma.
read more
Wednesday, October 31, 2018
Dr. Reddy’s Laboratories announced the launch of Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Stratter (atomoxetine) Capsules in the United States.
read more
Thursday, November 01, 2018
Lannett has approved a plan to sell Cody Laboratories, a subsidiary that produces active pharmaceutical ingredients (API) used in prescription pain medications.
read more
Monday, February 11, 2019
Codexis announces a multi-year, exclusive supply agreement with KYORIN Pharmaceutical for the supply of a proprietary enzyme to be used in the manufacture of vibegron, an active ingredient in Beova Tablets, a novel, once-daily treatment for ...
read more
Monday, February 11, 2019
Samsung Bioepis announced its expansion in mainland China through a licensing agreement with C-Bridge Capital.
read more
Tuesday, February 12, 2019
WuXi Biologics and Amicus Therapeutics announced that the companies have entered into an exclusive commercial manufacturing partnership for Amicus' Pompe biologic ATB200.
read more
Friday, February 15, 2019
The FDA has issued a final rule under section 503A of the FDCA, placing six bulk drug substances on the list of substances that compounders can use to compound drugs, known as the 503A bulks list.
read more
Friday, February 22, 2019
Assessing and mitigating risks is at the heart of everything we do across our vast portfolio.
read more
AGC has announced the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (MPC).
read more
GHO Capital has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture APIs.
read more
Asymchem announced its Tianjin1 site successfully completed a FDA general GMP reinspection conducted between January 14-18, 2019. No Form 483 was issued.
read more
Wednesday, March 27, 2019
STA Pharmaceutical WuXi STA announces its new drug product manufacturing facility in Waigaoqiao Free Trade Zone of Shanghai has passed its first GMP inspection by the European MPA.
read more
3M Drug Delivery Systems U.K. organization is bringing its teams under one roof in Loughborough.
read more
Ajinomoto Bio-Pharma Services announced GeneDesign has joined the global organization.
read more
Wednesday, April 10, 2019
Moleculin Biotech announced it has successfully expanded the clinical supply of Annamycin for its on-going clinical trials via BSP Pharmaceuticals S.p.A. in Latina, Italy.
read more